Pharmacotherapy of osteoporosis in men

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.1, 2005-01, pp. : 45-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety

By Reid Ian R

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 93-107

Informa Healthcare

Access to resources Recommend Favorite

Osteoporosis in older persons: current pharmacotherapy and future directions

By Duque Gustavo

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. : 1949-1958

Informa Healthcare

Access to resources Recommend Favorite

Alendronic acid effective for osteoporosis in men

Inpharma, Vol. 1, Iss. 1254, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions

By Bultink Irene EM Baden Marijke Lems Willem F

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 185-197

Informa Healthcare

Access to resources Recommend Favorite

Bisphosphonates to Prevent Osteoporosis in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

By Smith M.R.

Drugs & Aging, Vol. 20, Iss. 3, 2003-01 ,pp. : 175-183

Adis International

Access to resources Recommend Favorite